Free Trial

175,749 Shares in Cabot Co. (NYSE:CBT) Bought by Fiera Capital Corp

Cabot logo with Basic Materials background

Fiera Capital Corp acquired a new stake in Cabot Co. (NYSE:CBT - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 175,749 shares of the specialty chemicals company's stock, valued at approximately $19,643,000. Fiera Capital Corp owned 0.32% of Cabot at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Wolff Wiese Magana LLC acquired a new stake in Cabot in the third quarter valued at approximately $25,000. CWM LLC grew its holdings in Cabot by 60.6% in the second quarter. CWM LLC now owns 416 shares of the specialty chemicals company's stock valued at $38,000 after purchasing an additional 157 shares during the period. UMB Bank n.a. grew its holdings in Cabot by 53.9% in the third quarter. UMB Bank n.a. now owns 371 shares of the specialty chemicals company's stock valued at $41,000 after purchasing an additional 130 shares during the period. Farther Finance Advisors LLC lifted its position in shares of Cabot by 197.9% in the third quarter. Farther Finance Advisors LLC now owns 417 shares of the specialty chemicals company's stock valued at $47,000 after acquiring an additional 277 shares in the last quarter. Finally, EverSource Wealth Advisors LLC lifted its position in shares of Cabot by 33.4% in the second quarter. EverSource Wealth Advisors LLC now owns 475 shares of the specialty chemicals company's stock valued at $48,000 after acquiring an additional 119 shares in the last quarter. 93.18% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Cabot

In other news, CEO Sean D. Keohane sold 25,617 shares of Cabot stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $101.55, for a total value of $2,601,406.35. Following the completion of the sale, the chief executive officer now directly owns 331,174 shares of the company's stock, valued at approximately $33,630,719.70. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other news, CEO Sean D. Keohane sold 25,617 shares of Cabot stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $101.55, for a total value of $2,601,406.35. Following the completion of the sale, the chief executive officer now directly owns 331,174 shares of the company's stock, valued at approximately $33,630,719.70. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Jeff Ji Zhu sold 1,201 shares of the business's stock in a transaction on Monday, August 26th. The stock was sold at an average price of $106.19, for a total value of $127,534.19. Following the transaction, the executive vice president now directly owns 96,000 shares of the company's stock, valued at $10,194,240. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 48,665 shares of company stock worth $4,986,299 over the last quarter. 3.07% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on CBT shares. Mizuho raised their target price on Cabot from $103.00 to $122.00 and gave the company an "outperform" rating in a research report on Tuesday. UBS Group decreased their target price on Cabot from $103.00 to $98.00 and set a "neutral" rating on the stock in a research report on Tuesday, August 6th. Finally, JPMorgan Chase & Co. raised their target price on Cabot from $95.00 to $105.00 and gave the company a "neutral" rating in a research report on Wednesday, August 7th. Three analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $105.00.

Check Out Our Latest Stock Report on Cabot

Cabot Trading Down 1.4 %

Cabot stock traded down $1.61 during trading on Friday, reaching $114.99. 522,848 shares of the company were exchanged, compared to its average volume of 362,496. Cabot Co. has a 52-week low of $70.63 and a 52-week high of $117.46. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.08 and a quick ratio of 1.45. The company has a market capitalization of $6.30 billion, a P/E ratio of 17.06, a PEG ratio of 0.98 and a beta of 1.20. The stock's 50 day simple moving average is $109.13 and its two-hundred day simple moving average is $101.50.

Cabot (NYSE:CBT - Get Free Report) last posted its earnings results on Monday, November 4th. The specialty chemicals company reported $1.80 EPS for the quarter, missing analysts' consensus estimates of $1.81 by ($0.01). Cabot had a net margin of 9.51% and a return on equity of 26.60%. The business had revenue of $1 billion during the quarter, compared to analysts' expectations of $1.01 billion. During the same quarter in the prior year, the firm earned $1.65 EPS. Cabot's revenue for the quarter was up 3.7% compared to the same quarter last year. On average, equities research analysts expect that Cabot Co. will post 7.8 earnings per share for the current fiscal year.

Cabot Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 13th. Shareholders of record on Friday, November 29th will be given a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a yield of 1.50%. Cabot's dividend payout ratio is currently 25.52%.

About Cabot

(Free Report)

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

See Also

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Should you invest $1,000 in Cabot right now?

Before you consider Cabot, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.

While Cabot currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Star Bulk Carriers Stock 28% Upside: Can This Small Cap Deliver?

Star Bulk Carriers Stock 28% Upside: Can This Small Cap Deliver?

As global trade ramps up, especially with China's market expansion, could Star Bulk Carriers be your next big opportunity?

Related Videos

These 3 Small-Cap Stocks Could be the Hidden Gems of 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines